NewsRoom Articles - Page 100 of 154 - PsychedelicNewsWire (PNW)

WednesdayApr 28, 2021 3:00 pm

Trial Finds Psilocybin May Work as Effectively as Common Antidepressants

A clinical trial whose results were published last week has found that psilocybin may be used to treat depression. The phase 2 study was the first randomized trial that compared the effectiveness of commonly prescribed antidepressants with therapeutic doses of psilocybin. Its findings were reported in the “New England Journal of Medicine.” The trial was conducted by scientists from the Imperial College London. Despite the reported findings, there is still more that needs to be determined with regard to the use of psychedelics as a treatment for various mental health conditions, as researchers aren’t sure whether the substances, psilocybin included,…

WednesdayApr 28, 2021 11:56 am

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Retail Business to Bloom This Spring With Production of 50,000 Blister Packs

PULL starts production of roughly 50,000 blister pack gummies using Taste-T LLC’s successful proprietary manufacturing system Global CBD gummies market size estimated to grow at CAGR of 31.9% until 2025 PULL estimates $200,000 in revenue from initial batch, plans to produce three additional non-THC SKUs with varying levels of ultra-high potency CBD Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, recently announced it started production on roughly 50,000 Pure Chews edible gummy packs to be sold this Spring (https://ibn.fm/aEibn). The news came shortly…

TuesdayApr 27, 2021 2:30 pm

Former Texas Governor Implores Lawmakers to Pass Psychedelics Research Legislation

Former Republican Governor Rick Perry is backing legislation tabled by State Rep. Alex Dominguez, which pushes for psychedelic therapy treatments for veterans living with PTSD. The bill calls for a clinical study on psilocybin, which is the active ingredient found in magic mushrooms, to be conducted. In an interview last week, Perry stated that the measure was an optimistic piece of legislation that legislators have the opportunity to discuss during this session. Various studies have proposed that psilocybin could be an effective and safe treatment for various mental health conditions, such as depression. Perry noted that while he’s known to…

MondayApr 26, 2021 2:30 pm

Research Finds Previous Use of Antidepressants May Reduce MDMA Effectiveness Against PTSD

A study conducted recently proposes that psychedelic-assisted therapy using MDMA to help treat PTSD is not as efficacious among individuals who have recently used psychiatric drugs commonly prescribed by doctors, known as selective serotonin re-uptake inhibitors. The research findings were reported in the “Psychopharmacology” journal. Allison Feduccia, director of education platform Psychedelic Support and author of the study, explained that antidepressants, in particular SSRIs and MDMA, bound themselves to the same receptors in an individual’s brain. She noted that if an individual used selective serotonin reuptake inhibitors and MDMA concurrently, the effects of the psychedelic would be decreased. Feduccia added…

FridayApr 23, 2021 2:00 pm

New Study Suggests That Psilocybin Could Boost Neuroplasticity

Researchers from the University of Copenhagen in Denmark suggest that psilocybin, which is the main active ingredient found in magic mushrooms, may give rise to speedy and lasting antidepressant effects because it increases neuroplasticity in the brain. The study, which was reported in the “International Journal of Molecular Sciences,” has discovered evidence that psilocybin grows the number of neural connections in the hippocampus and prefrontal cortex of pig brains. Psilocybin has been shown to possess long-lasting and profound effects on mood and personality. However, the mechanisms behind these effects are still not clear. For their study, the scientists from Copenhagen…

ThursdayApr 22, 2021 2:00 pm

First-of-a-Kind Study Identifies Benefits of Group Psychedelic-Assisted Therapy Sessions

Psychedelics have become a popular topic of conversation, as well as of indulgence. While most of these substances remain outlawed in many countries across the globe, this has apparently not stopped people from accessing or using them. One of the reported common ways of consuming these drugs is in groups. Until recently, however, there hasn’t been any data to measure the possible value an individual derived from a group psychedelic experience. That has now changed. A new study that was published recently has found that using psychedelics within group settings (retreats or religious ceremonies, for example), could trigger increases in…

WednesdayApr 21, 2021 1:45 pm

Microdosing on Psychedelic Drugs Linked to Broad Range of Effects

In recent years, microdosing has become popular as a wellness trend, both in the United States as well as overseas in countries such as Australia. Microdosing involves consuming a low dose of a psychedelic drug to reduce anxiety and stress or boost performance. While there have been some accounts by consumers who sing the praises of psychedelics, questions about how much of the reported benefits stem from the substances’ pharmacological effects rather than the partaker’s expectations and beliefs, and how microdosing works, still remain. To help answer some of these questions, we’ll look at a few studies on microdosing and…

TuesdayApr 20, 2021 3:00 pm

Fireside Project Set to Launch Peer Support Line for Psychedelic Users

The Fireside Project is set to launch the first psychedelics peer support hotline in the world. Its creator, Joshua White, revealed that the concept behind the support line was to offer support to people who are experiencing an intense psychedelic trip or those who want to process an intense psychoactive experience they’ve gone through. White stated that the idea came to him last year, a few months into the coronavirus pandemic. He explained that the dark series of events that occurred during the summer, coupled with San Francisco’s infamous orange sky, led him to the realization that tied mental health…

MondayApr 19, 2021 12:40 pm

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Announces LOI Aimed at U.S. Expansion

Pure Extracts plans affiliate partnership to install cannabis and hemp extraction system in existing Michigan facility Company CEO notes excitement about launching into first US initiative with experienced and entrenched partners Agreement outlines planned renovation of existing 2,600-square-foot facility located in central Michigan Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp and functional mushrooms, has inked a letter of intent (“LOI”) to form a joint venture that paves the way for the company’s entrance into the United States. Based on the LOI, PULL will partner with the affiliate of a publicly traded multi-state…

MondayApr 19, 2021 11:31 am

Could Blockchain Tech Be a Boon for Psychedelics?

In the first few months of 2018, the Multidisciplinary Association for Psychedelic Studies was struggling to raise the finances it needed to conclude phase 3 of its clinical trials, which would allow the FDA to approve its MDMA-assisted therapy. Surprisingly, the funds were availed to the nonprofit organization through cryptocurrency. An anonymous individual, using the name Pine, created a philanthropic project that has made donations to 60 charities in the form of Bitcoin, known as the Pineapple Fund. The anonymous donor donated $5 million dollars’ worth of Bitcoin to MAPS, which enabled the organization to continue with its invaluable research…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000